Recommendations of follow-up after treatment of germ cell tumors Article Report uri icon

Overview

MeSH Major

  • Sarcoidosis
  • Seminoma
  • Testicular Neoplasms

abstract

  • Patients diagnosed with germ cell tumors (GCT) are relatively young, and most are rendered disease-free by primary treatment. Also, second-line therapies in nearly all instances are potentially curative. Therefore, the schedule and modalities of follow-up testing are important issues in detecting recurrence of GCT and for detecting secondary malignancies and complications of therapy. Follow-up is usually based on the pattern and probability of recurrence following primary therapy according to stage and histology. The National Comprehensive Cancer Network has outlined guidelines (www.nccn.org/physician_gls/index.html). There is a paucity of randomized data regarding the follow-up regimens most effective in identifying relapsed disease. Optimal means of imaging and frequency of physician visits and serum marker level measurements need to be further addressed.

publication date

  • June 2003

Research

keywords

  • Report

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0093-7754(03)00098-8

PubMed ID

  • 12870140

Additional Document Info

start page

  • 382

end page

  • 9

volume

  • 30

number

  • 3